These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 448944

  • 21. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S, Osiri M, Deesomchok U, Avihingsanon Y.
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [Abstract] [Full Text] [Related]

  • 22. Treatment of gout.
    Cohen MG.
    Intern Med J; 2011 Jan; 41(1a):70-1. PubMed ID: 21265967
    [No Abstract] [Full Text] [Related]

  • 23. Optimal management of chronic gout: attempting to render the (t)issues crystal-clear.
    Wong ML.
    N Z Med J; 2005 Jun 24; 118(1217):U1533. PubMed ID: 15980907
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Hyperuricemia and gout: therapeutic indications].
    Pawlotsky Y.
    Rev Prat; 1994 Jan 15; 44(2):206-9. PubMed ID: 8178077
    [Abstract] [Full Text] [Related]

  • 27. Approach to the treatment of hyperuricemia.
    Poon SH, Hall HA, Zimmermann B.
    Med Health R I; 2009 Nov 15; 92(11):359-62. PubMed ID: 19999894
    [No Abstract] [Full Text] [Related]

  • 28. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP.
    Munch Med Wochenschr; 1969 Feb 28; 111(9):491-5. PubMed ID: 5818966
    [No Abstract] [Full Text] [Related]

  • 29. [Treatment of hyperuricemia and gout].
    Gröbner W, Walter-Sack I.
    Med Monatsschr Pharm; 2005 May 28; 28(5):159-64; quiz 165-6. PubMed ID: 15912988
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Treatment of asymptomatic hyperuricemia].
    Floege J.
    Internist (Berl); 1997 Dec 28; 38(12):1233. PubMed ID: 9465329
    [No Abstract] [Full Text] [Related]

  • 32. Treatment of the gout and other forms of crystal-induced arthritis.
    Rodnan GP.
    Bull Rheum Dis; 1982 Dec 28; 32(5):43-53. PubMed ID: 6762236
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical inquiry. Are serum uric acid levels always elevated in acute gout?
    Leiszler M, Poddar S, Fletcher A.
    J Fam Pract; 2011 Oct 28; 60(10):618-20. PubMed ID: 21977490
    [Abstract] [Full Text] [Related]

  • 35. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
    Holländer E, Schwarczmann P.
    Munch Med Wochenschr; 1969 Aug 08; 111(32):1623-6. PubMed ID: 5394966
    [No Abstract] [Full Text] [Related]

  • 36. An open-label, 6-month study of allopurinol safety in gout: The LASSO study.
    Becker MA, Fitz-Patrick D, Choi HK, Dalbeth N, Storgard C, Cravets M, Baumgartner S.
    Semin Arthritis Rheum; 2015 Oct 08; 45(2):174-83. PubMed ID: 26190562
    [Abstract] [Full Text] [Related]

  • 37. Febuxostat versus allopurinol for gout.
    Lustberg ME.
    N Engl J Med; 2006 Apr 06; 354(14):1532-3; author reply 1532-3. PubMed ID: 16598054
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of gout.
    Goldfinger SE.
    N Engl J Med; 1971 Dec 02; 285(23):1303-6. PubMed ID: 4941493
    [No Abstract] [Full Text] [Related]

  • 39. Hyperuricemia and gout.
    Sloan RW.
    J Fam Pract; 1982 May 02; 14(5):923-6, 930-1, 934. PubMed ID: 7042900
    [Abstract] [Full Text] [Related]

  • 40. [Uricoeliminating or urico-inhibiting agents? Reasons for a choice].
    Cottin S, Prost A.
    Sem Hop; 1972 May 20; 48(24):1739-42. PubMed ID: 4340887
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.